pI: 7.8092 |
Length (AA): 119 |
MW (Da): 13517 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
23 | 119 | 2b95 (A) | 11 | 106 | 59.00 | 0 | 1 | 1.59 | -1.96 |
11 | 119 | 1y4o (A) | 1 | 104 | 56.00 | 0 | 1 | 1.64017 | -1.13 |
30 | 116 | 3l7h (A) | 9 | 94 | 64.00 | 0 | 1 | 1.63959 | -1.87 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | amastigotes. | Fernandes MC |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | metacyclic. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_128122)
Species | Accession | Gene Product |
---|---|---|
Brugia malayi | Bm1_24930 | dynein light chain 2B, cytoplasmic |
Caenorhabditis elegans | CELE_T24H10.6 | Protein DYRB-1 |
Cryptosporidium hominis | Chro.50229 | hypothetical protein |
Cryptosporidium parvum | cgd5_1550 | conserved hypothetical protein |
Dictyostelium discoideum | DDB_G0285855 | cytoplasmic dynein light chain |
Drosophila melanogaster | Dmel_CG15171 | CG15171 gene product from transcript CG15171-RA |
Drosophila melanogaster | Dmel_CG10751 | roadblock |
Echinococcus granulosus | EgrG_001043700 | dynein light chain |
Echinococcus granulosus | EgrG_001111200 | dynein light chain |
Echinococcus granulosus | EgrG_001111300 | dynein light chain |
Echinococcus multilocularis | EmuJ_001111300 | dynein light chain |
Echinococcus multilocularis | EmuJ_001043700 | dynein light chain |
Echinococcus multilocularis | EmuJ_001111200 | dynein light chain |
Giardia lamblia | GL50803_14270 | Dynein light chain |
Homo sapiens | ENSG00000168589 | dynein, light chain, roadblock-type 2 |
Homo sapiens | ENSG00000125971 | dynein, light chain, roadblock-type 1 |
Leishmania braziliensis | LbrM.34.1650 | dynein-associated roadblock protein-like protein |
Leishmania braziliensis | LbrM.18.1070 | dynein light chain 2B, cytoplasmic, putative |
Leishmania donovani | LdBPK_181010.1 | Outer arm dynein light chain 7 |
Leishmania donovani | LdBPK_351740.1 | dynein-associated roadblock protein-like protein |
Leishmania infantum | LinJ.18.1010 | dynein light chain 2B, cytoplasmic, putative |
Leishmania infantum | LinJ.35.1740 | dynein-associated roadblock protein-like protein |
Leishmania major | LmjF.18.1010 | dynein light chain 2B, cytoplasmic, putative |
Leishmania major | LmjF.35.1750 | dynein-associated roadblock protein-like protein |
Leishmania mexicana | LmxM.18.1010 | dynein light chain 2B, cytoplasmic, putative |
Leishmania mexicana | LmxM.34.1750 | dynein-associated roadblock protein-like protein |
Loa Loa (eye worm) | LOAG_01797 | dynein light chain 2B |
Mus musculus | ENSMUSG00000034467 | dynein light chain roadblock-type 2 |
Mus musculus | ENSMUSG00000047459 | dynein light chain roadblock-type 1 |
Neospora caninum | NCLIV_025350 | hypothetical protein |
Plasmodium berghei | PBANKA_0504400 | conserved Plasmodium protein, unknown function |
Plasmodium berghei | PBANKA_0504300 | flagellar outer arm dynein-associated protein, putative |
Plasmodium falciparum | PF3D7_1020100 | flagellar outer arm dynein-associated protein, putative |
Plasmodium falciparum | PF3D7_1020200 | conserved Plasmodium protein, unknown function |
Plasmodium knowlesi | PKNH_0604400 | conserved Plasmodium protein, unknown function |
Plasmodium knowlesi | PKNH_0604300 | roadblock/LC7 family member, putative |
Plasmodium vivax | PVX_001868 | hypothetical protein, conserved |
Plasmodium vivax | PVX_001872 | hypothetical protein, conserved |
Plasmodium yoelii | PY00604 | roadblock |
Plasmodium yoelii | PY00603 | hypothetical protein |
Schistosoma japonicum | Sjp_0076890 | ko:K10419 dynein light chain roadblock-type, putative |
Schistosoma mansoni | Smp_056780 | dynein light chain |
Schmidtea mediterranea | mk4.017572.00 | |
Schmidtea mediterranea | mk4.002498.02 | Dynein light chain, putative |
Schmidtea mediterranea | mk4.000280.07 | Dynein light chain roadblock-type 1 |
Schmidtea mediterranea | mk4.000879.01 | Dynein light chain, putative |
Schmidtea mediterranea | mk4.000421.03 | Dynein light chain, putative |
Trypanosoma brucei gambiense | Tbg972.10.15860 | dynein light chain 2B, cytoplasmic, putative,predicted dynein modulator,roadblock/LC7 family member |
Trypanosoma brucei | Tb927.9.14480 | dynein-associated protein, putative |
Trypanosoma brucei | Tb927.10.13110 | Outer arm dynein light chain 7 |
Trypanosoma cruzi | TcCLB.510761.73 | dynein-associated protein, putative |
Trypanosoma cruzi | TcCLB.503521.30 | Outer arm dynein light chain 7 |
Trypanosoma cruzi | TcCLB.506359.80 | Dynein light chain roadblock-type |
Toxoplasma gondii | TGME49_262480 | dynein light chain roadblock-type 2, putative |
Trichomonas vaginalis | TVAG_354740 | dynein light chain, putative |
Trichomonas vaginalis | TVAG_050160 | dynein light chain, putative |
Trichomonas vaginalis | TVAG_207270 | dynein light chain, putative |
Trichomonas vaginalis | TVAG_116140 | dynein light chain, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.13110 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.13110 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.13110 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.13110 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb09.211.4920 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb09.211.4920 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb09.211.4920 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb09.211.4920 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_T24H10.6 | Caenorhabditis elegans | embryonic lethal | wormbase |
PBANKA_0504400 | Plasmodium berghei | Slow | plasmo |
TGME49_262480 | Toxoplasma gondii | Essentiality uncertain | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.